ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $40.1 million in its second quarter.
On a per-share basis, the St. Helier, Jersey-based company said it had a loss of 36 cents.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
The oncology drug developer posted revenue of $158.8 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $153.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
